Substituted quinazolin-4-ylamine analogues
US7304059B2 · kind B2 · utility
3Cited by
32References
58Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2006 |
| Grant date | Dec 4, 2007 |
| Priority date | — |
| Expiry date | Feb 1, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted quinazolin-4-ylamine analogues are provided. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.